Introducing insights to streamline the workflow of upstream and downstream process development to accommodate diversifying pipelines.
Smart process development uses tools and methodologies to improve process outcomes and shorten time to market. When new modalities are adopted into the pipeline, there is often a lack of platform process solutions, making the pursuit of smart process development a potentially important differentiating factor. For example, the evolution of process development methods is shifting developers from examining one factor at a time to multivariate data analysis. This analysis employs statistical models such as Design of Experiments (DoE) and, more recently, equation-based mechanistic models. Additionally, the parallelization and automation of experimental setups known as high-throughput process development (HTPD) have made more information available with fewer samples. All of these tools and methodologies enable the acceleration of process development and enhance the understanding, robustness, and performance of processes overall. This eBook presents insights into the factors for conducting process development more smartly and quickly, as well as methods for streamlining workflows in upstream and downstream process development.
Inquire About This Product
basic information
This ebook is published in collaboration with BioPharm International, sponsored by Cytiva.
Applications/Examples of results
For more details, please feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.